Afuco™ Anti-Human IL21 ADCC Therapeutic Antibody (NN8828), ADCC Enhanced
Anti-IL21 ADCC Enhanced Antibody (NN8828) is an ADCC enhanced antibody produced by our Afuco™ platform. Anti-interleukin 21 monoclonal antibody, named NN 8828, is a recombinant fully human monoclonal antibody that was in Phase 2 development for IBD.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-398CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | IL21 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |